OTC Markets OTCPK - Delayed Quote USD

CNBX Pharmaceuticals Inc. (CNBX)

0.0023
+0.0003
+(15.00%)
At close: 3:53:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Total Revenue
0
130.0740
410.1650
29.9580
0
Operating Expense
323.9620
713.2140
1,341.5450
2,983.9280
2,600.1770
Operating Income
-306.3920
-583.1400
-931.3800
-2,953.9700
-2,600.1770
Net Non Operating Interest Income Expense
-20.2280
-19.6110
-55.9840
-1.2730
-61.3910
Other Income Expense
-4,355.8780
-92.4470
-2,722.8700
-1,437.1380
-532.8790
Pretax Income
-295.3560
-695.1980
-3,710.2340
-4,392.3810
-3,194.4470
Net Income Common Stockholders
-295.3560
-695.1980
-3,710.2340
-4,392.3810
-3,194.4470
Diluted NI Available to Com Stockholders
-295.3560
-695.1980
-3,710.2340
-4,392.3810
-3,194.4470
Basic EPS
0.00
-0.02
-0.42
-3.59
-2.40
Diluted EPS
0.00
-0.02
-0.42
-3.59
-2.40
Basic Average Shares
31,442.7560
30,247.6910
8,824.6360
1,222.6410
1,154.3290
Diluted Average Shares
31,442.7560
30,247.6910
8,824.6360
1,222.6410
1,154.3290
Total Operating Income as Reported
-306.3910
-583.1390
-931.3800
-2,953.9700
-2,600.1770
Total Expenses
306.3920
713.2140
1,341.5450
2,983.9280
2,600.1770
Interest Expense
8.1330
19.6110
1.1740
1.2730
2.3910
Net Interest Income
-20.2280
-19.6110
-55.9840
-1.2730
-61.3910
Net Income from Continuing & Discontinued Operation
-295.3560
-695.1980
-3,710.2340
-4,392.3810
-3,194.4470
Normalized Income
-326.6200
-602.7510
-987.3640
-3,677.4790
-3,368.4300
EBIT
-398.8390
-675.5870
-3,709.0600
-4,391.1080
-3,192.0560
EBITDA
-398.8390
-603.2670
-3,546.9990
-4,192.5810
-2,971.1300
Reconciled Depreciation
0
72.3200
162.0610
198.5270
220.9260
Net Income from Continuing Operation Net Minority Interest
-295.3560
-695.1980
-3,710.2340
-4,392.3810
-3,194.4470
Total Unusual Items Excluding Goodwill
31.2640
-92.4470
-2,722.8700
-714.9020
173.9830
Total Unusual Items
31.2640
-92.4470
-2,722.8700
-714.9020
173.9830
Normalized EBITDA
-430.1030
-510.8200
-824.1290
-3,477.6790
-3,145.1130
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
8/31/2021 - 7/23/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
 
EMMA Emmaus Life Sciences, Inc.
0.0130
0.00%
 
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
 
ANEB Anebulo Pharmaceuticals, Inc.
1.0700
-1.83%
 
NBIO Nascent Biotech, Inc.
0.0008
0.00%
 
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
 
HALB Halberd Corporation
0.0017
-5.56%
 
NBY NovaBay Pharmaceuticals, Inc.
0.5702
-1.69%
 
XBIO Xenetic Biosciences, Inc.
3.1488
-1.29%
 
SEER Seer, Inc.
1.8900
+2.16%